Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

HUMATIN

PAROMOMYCIN SULFATE

Standard Dose
EQ 125MG BASE/5ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview HUMATIN is listed in Drugs@FDA under application 060522 (ANDA).

Marketing status: Discontinued Active ingredient PAROMOMYCIN SULFATE Form and strength SYRUP;ORAL - EQ 125MG BASE/5ML Sponsor PARKE DAVIS Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview HUMATIN is listed in Drugs@FDA under application 060522 (ANDA). Marketing status: Discontinued Active ingredient PAROMOMYCIN SULFATE Form and strength SYRUP;ORAL - EQ 125MG BASE/5ML Sponsor PARKE DAVIS Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.